Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel D Allen

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Frontiers in Immunology|November 15, 2023
Fcγ receptor binding is required for maximal immunostimulation by CD70-FcOsman Dadas, Joel D Allen, Sarah L Buchan, et al.
Plos Pathogens|July 16, 2019
Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimeticsAlba Torrents de la Peña, Kimmo Rantalainen, Christopher A Cottrell, et al.
Nature Communications|May 29, 2020
Vulnerabilities in coronavirus glycan shields despite extensive glycosylationYasunori Watanabe, Zachary T Berndsen, Jayna Raghwani, et al.
Mbio|June 22, 2021
Neutralizing Antibodies Induced by First-Generation gp41-Stabilized HIV-1 Envelope Trimers and NanoparticlesSonu Kumar, Xiaohe Lin, Timothy Ngo, et al.
Biotechnology and Bioengineering|July 5, 2022
Augmenting glycosylation-directed folding pathways enhances the fidelity of HIV Env immunogen production in plantsEmmanuel Margolin, Joel D Allen, Matthew Verbeek, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Design and immunogenicity of an HIV-1 clade C pediatric envelope glycoprotein stabilized by multiple platformsSanjeev Kumar, Iván Del Moral-Sánchez, Swarandeep Singh, et al.
Science (New York, N.Y.)|October 20, 2022
Structure of the hepatitis C virus E1E2 glycoprotein complexAlba Torrents de la Peña, Kwinten Sliepen, Lisa Eshun-Wilson, et al.
Plos Pathogens|October 30, 2023
Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralizationRajesh P Ringe, Philippe Colin, Gabriel Ozorowski, et al.
Frontiers in Plant Science|March 24, 2023
A plant-produced SARS-CoV-2 spike protein elicits heterologous immunity in hamstersEmmanuel Margolin, Georgia Schäfer, Joel D Allen, et al.
Science Translational Medicine|March 18, 2021
Effector function does not contribute to protection from virus challenge by a highly potent HIV broadly neutralizing antibody in nonhuman primatesLars Hangartner, David Beauparlant, Eva Rakasz, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|November 15, 2023
Fcγ receptor binding is required for maximal immunostimulation by CD70-FcOsman Dadas, Joel D Allen, Sarah L Buchan, et al.
Plos Pathogens|July 16, 2019
Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimeticsAlba Torrents de la Peña, Kimmo Rantalainen, Christopher A Cottrell, et al.
Nature Communications|May 29, 2020
Vulnerabilities in coronavirus glycan shields despite extensive glycosylationYasunori Watanabe, Zachary T Berndsen, Jayna Raghwani, et al.
Mbio|June 22, 2021
Neutralizing Antibodies Induced by First-Generation gp41-Stabilized HIV-1 Envelope Trimers and NanoparticlesSonu Kumar, Xiaohe Lin, Timothy Ngo, et al.
Biotechnology and Bioengineering|July 5, 2022
Augmenting glycosylation-directed folding pathways enhances the fidelity of HIV Env immunogen production in plantsEmmanuel Margolin, Joel D Allen, Matthew Verbeek, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Design and immunogenicity of an HIV-1 clade C pediatric envelope glycoprotein stabilized by multiple platformsSanjeev Kumar, Iván Del Moral-Sánchez, Swarandeep Singh, et al.
Science (New York, N.Y.)|October 20, 2022
Structure of the hepatitis C virus E1E2 glycoprotein complexAlba Torrents de la Peña, Kwinten Sliepen, Lisa Eshun-Wilson, et al.
Plos Pathogens|October 30, 2023
Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralizationRajesh P Ringe, Philippe Colin, Gabriel Ozorowski, et al.
Frontiers in Plant Science|March 24, 2023
A plant-produced SARS-CoV-2 spike protein elicits heterologous immunity in hamstersEmmanuel Margolin, Georgia Schäfer, Joel D Allen, et al.
Science Translational Medicine|March 18, 2021
Effector function does not contribute to protection from virus challenge by a highly potent HIV broadly neutralizing antibody in nonhuman primatesLars Hangartner, David Beauparlant, Eva Rakasz, et al.
Pageof 10